Cannabis & Hemp Stocks Investment Tools – Schedule Demo Now!

Strong Buy: Aurora Cannabis Shares Receives Bump from Analyst Recommendation, Tumbles with Sector after FDA Chief Resigns

Aurora Cannabis (NYSE: ACB)Strong Buy: Aurora Cannabis Shares Receives Bump from Analyst Recommendation, Tumbles with Sector after FDA Chief Resigns has been put between what could be considered as a rock and a hard place. The company, recently favored by Cowen & Co analysts, immediately faced decreases in value that similar cannabis corporations within the cannabis sector felt today. Cannabis stocks fell across the board after FDA Chief Dr. Scott Gottlieb announced his resignation.

Despite the news: we would recommend purchasing shares in ACB at this time.

Vivien Azer, established analyst at Cowen & Co, placed an Outperform rating on Aurora Cannabis with a price point target of $10.50 or C$14. Cowen analysts touted the company’s ability to capture 20% of the Canadian cannabis market share and its large cultivation footprint of 575,000kg.

{{cta(’69f63bd3-e695-415f-8c83-b207c29317a6′)}}

“While establishing 20% market share has been an early success story in Canadian adult use cannabis, the company is uniquely positioned to drive leadership in both share and profitability,” said Azer.

ACB shares peaked at $8.42 today, before it tumbled, and is currently at a 9.29% increase after market close on Monday of this week. After the Cowen announcement, the value of ACB rose more than 12% on Tuesday, and continued for another 2.59% until it hit the $8.42 peak in value on Wednesday.

Curious about other cannabis stocks with massive growth potential? Sign up for Cannin Free Access and subscribe to the Cannin Chronicle. We’ll keep you informed on all things cannabis and even help you determine which cannabis companies have the highest growth potential.

Source

Strong Buy: Aurora Cannabis Shares Receives Bump from Analyst Recommendation, Tumbles with Sector after FDA Chief Resigns

About Cannin: Your Cannabis Stocks Resource

Cannin is your #1 trusted resource for cannabis stocks. Our global team of experts evaluates all emerging cannabis stock investing opportunities. We aggregate hundreds of hours of financial research and provide tips on the best cannabis stocks for 2020. 

Use Cannin as your resource for:

Market analysts expect the marijuana and hemp industry will have an annual value exceeding $75 Billion in the next decade. Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.

Are you looking to buy stock in hemp companies or marijuana companies for 2020? Interested in new penny hemp stock companies? Looking for the best Canadian cannabis stocks to invest in? Looking to leverage the power of algorithmic stock trading to beat the cannabis market? We can help.

Are you interested in cannabis stocks like Curaleaf, Trulieve, Aurora Cannabis, Charlotte’s Web, Canopy Growth, or Hemp Inc.?

Predict price movements of cannabis stocks several hours in advance with our proprietary algorithmic stock trading software.

  • +25% Gains in 2020
  • +49.8% Gains in 2019
  • Backtested since 2012

We’re so confident you’ll love our algotrading cannabis stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.

Profit from the best cannabis stocks – we’ll show you how at cannin.com.

Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Best Hemp Stocks to Invest In

Strong Buy: Aurora Cannabis Shares Receives Bump from Analyst Recommendation, Tumbles with Sector after FDA Chief Resigns